Valeant Pharmaceuticals reported $23.44B in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Amgen AMGN:US $ 32782M 97M
Ani Pharmaceuticals ANIP:US $ 204.71M 21.28M
Aphria Inc APH:CN C$ 928.67M 381.15M
Aurora Cannabis Inc ACB:CN 399.55M 81.37M
Biogen BIIB:US $ 7271.1M 1.9M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Canopy Growth Corp WEED:CN C$ 1.69B 45.4M
Catalent CTLT:US $ 3241M 17.8M
Corcept Therapeutics CORT:US $ 0M 0M
Danaher DHR:US $ 20423M 146M
Drreddys Laboratories RDY:US $ 33373M 3065M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Endo International Ordinary Shares ENDP:US $ 8304.11M 3.58M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2576.44M 2.07M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Lannett LCI:US $ 590.68M 20.02M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 475.39M 6.4M
Perrigo Ordinary Shares PRGO:US $ 3555.9M 5.2M
Phibro Animal Health PAHC:US $ 392.08M 11.86M
Prestige Brands PBH:US $ 1554.12M 65.06M
Revance Therapeutics RVNC:US $ 280M 0.31M
Supernus Pharmaceuticals SUPN:US $ 370.38M 18.83M
Valeant Pharmaceuticals VRX:CN $ 23439M 299M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Zoetis ZTS:US $ 7196M 5M